Bill > SB0397

This bill amends Michigan's social welfare act to expand exemptions from prior authorization requirements for certain prescription drugs under the state's Medicaid program. The bill specifically eliminates prior authorization requirements for prescription drugs used to treat central nervous system conditions, mental health disorders, HIV/AIDS, cancer, organ replacement therapy, epilepsy, and opioid-related conditions. A notable addition is the explicit exemption for prescription drugs treating opioid withdrawal symptom management and opioid use disorder, with a specific provision preventing the department from imposing dosage maximums for these medications. The bill defines key terms like "prior authorization" (a process that conditions or delays pharmaceutical services based on predetermined criteria) and "cross-indicated" (drugs used for purposes generally considered medically appropriate even if not FDA-approved for that specific use). The exemptions apply to drugs provided through health maintenance organizations and Medicaid contracts, ensuring that patients can more easily access these critical medications without administrative barriers. The goal appears to be reducing bureaucratic hurdles that might otherwise prevent patients from receiving necessary medical treatments.

Business and Industry, Health and Social Services

https://legislature.mi.gov/Bills/Bill?ObjectName=2025-SB-0397